Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Buonamici

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Leukemia Research|January 1, 2008
Hexamethylene bisacetamide as a treatment for T-cell leukemia (T-ALL)Silvia Buonamici, Iannis Aifantis
Cell Cycle (Georgetown, Tex.)|March 3, 2007
Notches, NFkappaBs and the making of T cell leukemiaIannis Aifantis, Tomas Vilimas, Silvia Buonamici
Nature Reviews. Immunology|April 19, 2008
Molecular pathogenesis of T-cell leukaemia and lymphomaIannis Aifantis, Elizabeth Raetz, Silvia Buonamici
Blood Cells, Molecules & Diseases|September 16, 2003
The role of EVI1 in normal and leukemic cellsSilvia Buonamici, Soumen Chakraborty, Vitalyi Senyuk, et al.
Current Opinion in Genetics & Development|November 15, 2017
Targeting splicing abnormalities in cancerAnant A Agrawal, Lihua Yu, Peter G Smith, et al.
Biochemical and Biophysical Research Communications|July 25, 2003
P/CAF and GCN5 acetylate the AML1/MDS1/EVI1 fusion oncoproteinVitalyi Senyuk, Kislay Kumar Sinha, Soumen Chakraborty, et al.
Haematologica|May 16, 2002
Two more inv(16) acute myeloid leukemia cases with infrequent CBFbeta-MYH11 fusion transcript: clinical and molecular findingsGiovanni Martinelli, Emanuela Ottaviani, Silvia Buonamici, et al.
Haematologica|February 3, 2004
Patterns of AML1-ETO transcript expression in patients with acute myeloid leukemia and t(8;21) in complete hematologic remissionSilvia Buonamici, Emanuela Ottaviani, Giuseppe Visani, et al.
Haematologica|April 13, 2004
Molecular monitoring to identify a threshold of CBFbeta/MYH11 transcript below which continuous complete remission of acute myeloid leukemia inv16 is likelyGiovanni Martinelli, Michela Rondoni, Silvia Buonamici, et al.
Seminars in Hematology|June 11, 2004
Targeted therapies in myelodysplastic syndromes: ASH 2003 reviewAnna Candoni, Federico Silvestri, Silvia Buonamici, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Leukemia Research|January 1, 2008
Hexamethylene bisacetamide as a treatment for T-cell leukemia (T-ALL)Silvia Buonamici, Iannis Aifantis
Cell Cycle (Georgetown, Tex.)|March 3, 2007
Notches, NFkappaBs and the making of T cell leukemiaIannis Aifantis, Tomas Vilimas, Silvia Buonamici
Nature Reviews. Immunology|April 19, 2008
Molecular pathogenesis of T-cell leukaemia and lymphomaIannis Aifantis, Elizabeth Raetz, Silvia Buonamici
Blood Cells, Molecules & Diseases|September 16, 2003
The role of EVI1 in normal and leukemic cellsSilvia Buonamici, Soumen Chakraborty, Vitalyi Senyuk, et al.
Current Opinion in Genetics & Development|November 15, 2017
Targeting splicing abnormalities in cancerAnant A Agrawal, Lihua Yu, Peter G Smith, et al.
Biochemical and Biophysical Research Communications|July 25, 2003
P/CAF and GCN5 acetylate the AML1/MDS1/EVI1 fusion oncoproteinVitalyi Senyuk, Kislay Kumar Sinha, Soumen Chakraborty, et al.
Haematologica|May 16, 2002
Two more inv(16) acute myeloid leukemia cases with infrequent CBFbeta-MYH11 fusion transcript: clinical and molecular findingsGiovanni Martinelli, Emanuela Ottaviani, Silvia Buonamici, et al.
Haematologica|February 3, 2004
Patterns of AML1-ETO transcript expression in patients with acute myeloid leukemia and t(8;21) in complete hematologic remissionSilvia Buonamici, Emanuela Ottaviani, Giuseppe Visani, et al.
Haematologica|April 13, 2004
Molecular monitoring to identify a threshold of CBFbeta/MYH11 transcript below which continuous complete remission of acute myeloid leukemia inv16 is likelyGiovanni Martinelli, Michela Rondoni, Silvia Buonamici, et al.
Seminars in Hematology|June 11, 2004
Targeted therapies in myelodysplastic syndromes: ASH 2003 reviewAnna Candoni, Federico Silvestri, Silvia Buonamici, et al.
Pageof 6